The Scromiting Scare: A Factual Rebuttal

Filed Under: The Panic Desk

---

The CDC recorded a sharp rise in CHS-coded emergency visits after hospitals received a dedicated diagnosis code. The Hill framed that coding jump as a surge in cases among teens and young adults.

Bad health reporting can turn a caveat into roadkill. The alarming number goes in the headline while the explanation gets dragged behind the car.

The Hill’s CHS headline does exactly that.

Addy Bink, a national digital content producer for Nexstar Media Group, wrote:

“Cases of ‘scromiting’ condition tied to cannabis use spike among teens, young adults: New study”.

The CDC report Bink covered examined emergency-department visits involving cannabis hyperemesis syndrome from January 2023 through May 2026. Researchers wanted to see what happened after hospitals received a diagnosis code created specifically for CHS.

They got their answer on October 1, 2025.

The recorded rate leaped from 3.35 CHS-related visits per 10,000 emergency encounters in September to 11.26 in October. During the following eight months, the monthly average reached 11.97. That was 3.7 times the average recorded before the new code.

Diseases do not usually wait for the first day of the federal coding year before exploding across the country. Paperwork does.

The CDC described the jump this way:

“Likely reflects, at least in part, improved clinical recognition and coding of CHS rather than a true and immediate rise in incidence.”

Its pre-code trend had remained mostly steady for nearly three years.

Researchers also said the higher rate might provide a better estimate of a syndrome that hospitals had previously missed. During the limited post-code period, they observed a possible increase among people ages 15 through 24 and 25 through 34.

Both findings belong in the story. CHS may have been undercounted before R11.16, but the cliff in the graph appeared when the method of counting changed.

The Hill mentioned the new code in the body. Then its headline went out and told a much cleaner scare story.

The CDC counted emergency encounters involving CHS. The Hill called them cases.

That swap looks harmless until the number arrives.

199,565 looks like a body count. It was a visit count.

One patient can visit an emergency department several times. Each encounter enters the database as another record, which carries enormous weight when the syndrome being tracked involves recurring vomiting episodes.

The CDC report does not state how many unique patients generated those encounters. The Hill called them cases anyway.

A headline about rising “cases” invites readers to picture rising numbers of individual patients. The CDC reported 199,565 visits, not 199,565 people.

The headline performed another trick with age.

The CDC handed The Hill one age bin marked 15–24. The headline unpacked it into teenagers and young adults as if the data had done the sorting.

It had not.

People ages 15 through 19 are teenagers. Those between 20 and 24 are adults. The published table combines both populations and offers no way to determine which one produced most of the elevated rate.

Patients between 11 and 14 received their own category. Their post-code rate was 3.19 visits per 10,000 emergency encounters. The combined 15-to-24 group reached 38.70.

That gap deserves investigation. It does not reveal how the older category divides.

Teenagers may account for much of the elevated rate. Adults in their early twenties may account for more. The CDC table cannot settle it, but The Hill found enough confidence to separate them in the headline.

Then came the word built to make the whole thing travel.

The CDC called it CHS. The Hill chose “scromiting.” A diagnosis informs readers. Gross-out slang grabs them by the collar.

“Scromiting” combines screaming with vomiting. It turns a complicated syndrome into a carnival act and gives the headline an image no frightened parent will forget.

The term appears nowhere in the CDC report. It is slang, not clinical terminology. Clinicians diagnose cannabis hyperemesis syndrome.

The quotation marks offer no protection from the choice. The Hill could have centered the coding change that produced the statistical break. Instead, it shoved the ugliest slang available to the front of the story.

CHS is real, and that should make sloppy coverage less tolerable.

The original Australian case series followed heavy cannabis users suffering from recurrent vomiting. Seven recovered after stopping cannabis. Three resumed use and experienced another episode, while two recovered again after quitting.

That stop-and-restart pattern offers serious evidence of a causal relationship in some patients. Pot Culture Magazine has no interest in pretending otherwise.

A real syndrome can still be overdiagnosed, inconsistently defined, and mangled by reporting that turns it into an easy menace.

Cannabis users can also suffer from cyclic vomiting syndrome. Similar symptoms may come from gastrointestinal disease, infection, metabolic disorders, medication reactions, pregnancy-related nausea, withdrawal, or other causes.

Hot bathing offers no diagnostic shortcut. The behavior appears frequently in CHS reports, but people with cyclic vomiting syndrome also use hot water for relief.

A credible diagnosis often depends on what happens after the emergency visit. Rome IV requires symptom relief following sustained cannabis cessation. The American Gastroenterological Association recommends abstinence lasting at least six months or three typical vomiting cycles.

An emergency-room code cannot perform that follow-up.

A review led by gastroenterologist Thangam Venkatesan compiled 376 reported CHS cases. Only 59 met the Rome IV standard, which amounts to 15.7 percent.

Many of those reports predated Rome IV. Others lacked enough follow-up to establish whether sustained abstinence ended the symptoms. Researchers found wildly inconsistent diagnostic standards and continuing difficulty separating CHS from cyclic vomiting syndrome among cannabis users.

That record supports CHS while shredding the idea that every label carries equal certainty.

The CDC study inherits those complications because its evidence came from administrative records. Before October 2025, researchers searched for vomiting codes paired with cannabis-related diagnoses. After R11.16 appeared, they added the new code while continuing to count encounters captured through the earlier method.

---

M O R E F R O M P O T C U L T U R E M A G A Z I N E

---

The case definition changed during the study period. The largest increase arrived at the exact moment hospitals received a more precise label.

That does not make the later numbers worthless. It makes the coding change the main event.

The Hill treated it like explanatory fine print.

Even the CDC’s data source came with limits. Researchers analyzed 3,636 emergency departments that consistently supplied usable information, representing 70 percent of eligible facilities. The report warned that the results were not completely generalizable.

Identification also depended on clinician recognition, medical documentation, and patient self-report. The CDC acknowledged that CHS-related visits could still be missed or misclassified after R11.16 entered use.

Those facts do not erase the burden of CHS. They demolish the false precision created when coded encounters become cases and a blended age group splits itself for a headline.

The Hill also managed to inflate the authority behind the new code.

Its article says the World Health Organization added CHS to its diagnostic manual in October.

That is wrong.

R11.16 belongs to ICD-10-CM, the Clinical Modification developed for use in the United States. WHO maintains the parent ICD classification. The CDC’s National Center for Health Statistics manages the American modification through a domestic federal process.

R11.16 is an American diagnostic code used for reporting and billing. The Hill promoted it to a global medical decree.

That promotion gives the story more authority than the facts allow. “WHO added CHS” sounds like an international medical judgment descending from Geneva. The truth involves an American coding committee creating a more precise way to record hospital diagnoses.

This was not buried in an obscure archive. NCHS explains the system on the same federal website that published the CHS report.

The story also leans on stronger cannabis as part of its atmosphere.

The CDC did not know what patients consumed, how potent it was, or whether it came as flower, concentrate, edible, or vape. The records contained no product-level information.

The Hill included stronger cannabis among the possible explanations. The CDC, however, stated that THC concentration has not been directly linked to CHS and called for more surveillance of potency, product type, and route of use.

Higher potency may encourage more frequent consumption, which the CDC identifies as a major CHS risk factor. That indirect relationship deserves investigation. It belongs among the unanswered questions, not beside the findings as if the connection had already been established.

Product type matters for the same reason. Smoking flower and repeatedly inhaling concentrated oil are not interchangeable exposure patterns. Edibles bring their own dosing problems, while vape cartridges vary in formulation and strength.

The CDC had none of those details.

That absence leaves a major hole in understanding who develops CHS and under what conditions. The report admits the hole. Its placement gives stronger cannabis more explanatory weight than the evidence can carry.

No one needs to minimize CHS to expose this reporting.

---

---

Frequent users should know that recurrent vomiting may be connected to cannabis. Clinicians should ask about duration, dose, frequency, product type, and route of use. Patients also need follow-up strong enough to distinguish CHS from conditions that resemble it.

Public-health journalism has the same obligation to distinguish one thing from another.

A hospital encounter is not automatically a unique patient. A new code is not proof of a sudden outbreak. A 15-to-24 age category cannot report separate rates for teenagers and young adults. An American clinical modification did not come from WHO.

The Hill had every piece needed to write an accurate story. The coding caveat appears in the CDC abstract. The age brackets sit in the table. Misclassification appears in the limitations. Product uncertainty appears in the recommendations.

Nobody had to crack a safe or decode a medical conspiracy.

Alarmist framing does not require fabrication. The number stays true but receives a more frightening name. A broad age bracket becomes a youth crisis. A revolting nickname takes the headline while the qualification that explains the spike waits below.

The Hill did not invent CHS. It took a real syndrome, a real coding change, and a real set of emergency visits, then squeezed them into a headline more certain than the evidence.

The CDC gave The Hill a coding story with medical consequences. The Hill dressed it as a teen weed emergency and put “scromiting” in the headline.

---

©2026 Pot Culture Magazine. All Rights Reserved. This is the property of Pot Culture Magazine and is protected by U.S. and international copyright laws. Unauthorized reproduction, distribution, or transmission of this work, in part or in whole, without the express written permission of Pot Culture Magazine is strictly prohibited.

---

F O R T H E C U L T U R E B Y T H E C U L T U R E